1. Contribution of central amiloride-sensitive transport systems to the development of hypertension in spontaneously hypertensive rats
- Author
-
Shoichi Nagao, Shin-ichi Kitamura, Masaharu Nonaka, Masazumi Akahoshi, Katsusuke Yano, and Shinji Seto
- Subjects
Male ,medicine.medical_specialty ,Sympathetic Nervous System ,Ganglionic Blockers ,Blood Pressure ,Hexamethonium ,Rats, Inbred WKY ,Amiloride ,Norepinephrine (medication) ,Norepinephrine ,chemistry.chemical_compound ,Rats, Inbred SHR ,Internal medicine ,Animals ,Medicine ,Diuretics ,Molecular Biology ,business.industry ,Angiotensin II ,General Neuroscience ,Body Weight ,Sodium ,Brain ,Water-Electrolyte Balance ,Rats ,Autonomic nervous system ,Blood pressure ,Endocrinology ,chemistry ,Hypertension ,Catecholamine ,Neurology (clinical) ,Carrier Proteins ,business ,Artificial cerebrospinal fluid ,Developmental Biology ,medicine.drug - Abstract
This study was conducted to examine if central amiloride-sensitive transport systems are involved in the development and/or maintenance of hypertension in spontaneously hypertensive rats (SHR). Either amiloride (75 microg/60 microl/day) or artificial cerebrospinal fluid (aCSF, 60 microl/day) was infused centrally (i.c.v.) for 4 weeks to development (4-5-weeks-old) and maintenance (10-12-weeks-old) phases of hypertension in SHR. In development phase, amiloride i.c.v. (n=14) blunted the elevation of blood pressure (BP) compared to aCSF i.c.v. (n=9) (amiloride vs. aCSF; after 3 weeks of i.c.v., 146+/-3 vs. 166+/-5 mmHg, P
- Published
- 2001